Carotid plaque associations among hypertensive patients

L. Michael Prisant, Paula C. Zemel, Fenwick T Nichols, Michael B. Zemel, James R. Sowers, Albert A. Carr, William O. Thompson, M. Gene Bond

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Objective: To assess the relationship between cardiovascular risk factors and carotid plaque. Design: Hypertensive patients were screened for randomization into the Multicenter Isradipine Diuretic Atherosclerosis Study, a trial intended to determine if blood pressure control by isradipine as compared with hydrochlorothiazide will blunt the progression of carotid plaque (intima plus media thickness, 1.3 to 3.5 mm) in patients with serum cholesterol levels of less than 6.85 mmol/L (265 mg/dL) without insulin-dependent diabetes mellitus or estrogen therapy. Demographics of those who underwent B-mode ultrasound evaluations at common, bifurcation, and internal carotid artery sites to detect plaque were assessed from a southern and a northern site. Setting: Participants were from ambulatory outpatient clinics associated with medical schools. Patients: The initial screening included 1823 hypertensive volunteer patients who were between 40 and 83 years of age who had a diastolic pressure of 90 to 114 mm Hg (or <90 mm Hg with treatment). Outcome Measures: Complete data were collected on the variables of age, cholesterol, cigarette smoking, race, gender, and the presence of carotid plaque in 1126 patients. Results: All variables were significantly associated with carotid plaque (intima plus media thickness, ≥1.3 mm). The adjusted percentage with plaque was 66.4%±3.4% for blacks and 70.1%±2.3% for whites at the southern site and 42.7%±4.5% for blacks and 61.3%±3.2% for whites at the northern site. The rate of plaque was 75.8% among cigarette smokers, despite a mildly elevated cholesterol level. Conclusions: Although these 1126 cases do not constitute a random sample of patients, these data suggest that there may be regional differences in racial tendencies toward plaque among blacks.

Original languageEnglish (US)
Pages (from-to)501-506
Number of pages6
JournalArchives of Internal Medicine
Volume153
Issue number4
StatePublished - Feb 22 1993

Fingerprint

Isradipine
Cholesterol
Blood Pressure
Hydrochlorothiazide
Common Carotid Artery
Internal Carotid Artery
Random Allocation
Ambulatory Care Facilities
Hypercholesterolemia
Medical Schools
Type 1 Diabetes Mellitus
Diuretics
Tobacco Products
Volunteers
Atherosclerosis
Estrogens
Smoking
Demography
Outcome Assessment (Health Care)
Therapeutics

ASJC Scopus subject areas

  • Internal Medicine

Cite this

Prisant, L. M., Zemel, P. C., Nichols, F. T., Zemel, M. B., Sowers, J. R., Carr, A. A., ... Bond, M. G. (1993). Carotid plaque associations among hypertensive patients. Archives of Internal Medicine, 153(4), 501-506.

Carotid plaque associations among hypertensive patients. / Prisant, L. Michael; Zemel, Paula C.; Nichols, Fenwick T; Zemel, Michael B.; Sowers, James R.; Carr, Albert A.; Thompson, William O.; Bond, M. Gene.

In: Archives of Internal Medicine, Vol. 153, No. 4, 22.02.1993, p. 501-506.

Research output: Contribution to journalArticle

Prisant, LM, Zemel, PC, Nichols, FT, Zemel, MB, Sowers, JR, Carr, AA, Thompson, WO & Bond, MG 1993, 'Carotid plaque associations among hypertensive patients', Archives of Internal Medicine, vol. 153, no. 4, pp. 501-506.
Prisant LM, Zemel PC, Nichols FT, Zemel MB, Sowers JR, Carr AA et al. Carotid plaque associations among hypertensive patients. Archives of Internal Medicine. 1993 Feb 22;153(4):501-506.
Prisant, L. Michael ; Zemel, Paula C. ; Nichols, Fenwick T ; Zemel, Michael B. ; Sowers, James R. ; Carr, Albert A. ; Thompson, William O. ; Bond, M. Gene. / Carotid plaque associations among hypertensive patients. In: Archives of Internal Medicine. 1993 ; Vol. 153, No. 4. pp. 501-506.
@article{13991296c2f54d9e8939ebf6fbac51ca,
title = "Carotid plaque associations among hypertensive patients",
abstract = "Objective: To assess the relationship between cardiovascular risk factors and carotid plaque. Design: Hypertensive patients were screened for randomization into the Multicenter Isradipine Diuretic Atherosclerosis Study, a trial intended to determine if blood pressure control by isradipine as compared with hydrochlorothiazide will blunt the progression of carotid plaque (intima plus media thickness, 1.3 to 3.5 mm) in patients with serum cholesterol levels of less than 6.85 mmol/L (265 mg/dL) without insulin-dependent diabetes mellitus or estrogen therapy. Demographics of those who underwent B-mode ultrasound evaluations at common, bifurcation, and internal carotid artery sites to detect plaque were assessed from a southern and a northern site. Setting: Participants were from ambulatory outpatient clinics associated with medical schools. Patients: The initial screening included 1823 hypertensive volunteer patients who were between 40 and 83 years of age who had a diastolic pressure of 90 to 114 mm Hg (or <90 mm Hg with treatment). Outcome Measures: Complete data were collected on the variables of age, cholesterol, cigarette smoking, race, gender, and the presence of carotid plaque in 1126 patients. Results: All variables were significantly associated with carotid plaque (intima plus media thickness, ≥1.3 mm). The adjusted percentage with plaque was 66.4{\%}±3.4{\%} for blacks and 70.1{\%}±2.3{\%} for whites at the southern site and 42.7{\%}±4.5{\%} for blacks and 61.3{\%}±3.2{\%} for whites at the northern site. The rate of plaque was 75.8{\%} among cigarette smokers, despite a mildly elevated cholesterol level. Conclusions: Although these 1126 cases do not constitute a random sample of patients, these data suggest that there may be regional differences in racial tendencies toward plaque among blacks.",
author = "Prisant, {L. Michael} and Zemel, {Paula C.} and Nichols, {Fenwick T} and Zemel, {Michael B.} and Sowers, {James R.} and Carr, {Albert A.} and Thompson, {William O.} and Bond, {M. Gene}",
year = "1993",
month = "2",
day = "22",
language = "English (US)",
volume = "153",
pages = "501--506",
journal = "JAMA Internal Medicine",
issn = "2168-6106",
publisher = "American Medical Association",
number = "4",

}

TY - JOUR

T1 - Carotid plaque associations among hypertensive patients

AU - Prisant, L. Michael

AU - Zemel, Paula C.

AU - Nichols, Fenwick T

AU - Zemel, Michael B.

AU - Sowers, James R.

AU - Carr, Albert A.

AU - Thompson, William O.

AU - Bond, M. Gene

PY - 1993/2/22

Y1 - 1993/2/22

N2 - Objective: To assess the relationship between cardiovascular risk factors and carotid plaque. Design: Hypertensive patients were screened for randomization into the Multicenter Isradipine Diuretic Atherosclerosis Study, a trial intended to determine if blood pressure control by isradipine as compared with hydrochlorothiazide will blunt the progression of carotid plaque (intima plus media thickness, 1.3 to 3.5 mm) in patients with serum cholesterol levels of less than 6.85 mmol/L (265 mg/dL) without insulin-dependent diabetes mellitus or estrogen therapy. Demographics of those who underwent B-mode ultrasound evaluations at common, bifurcation, and internal carotid artery sites to detect plaque were assessed from a southern and a northern site. Setting: Participants were from ambulatory outpatient clinics associated with medical schools. Patients: The initial screening included 1823 hypertensive volunteer patients who were between 40 and 83 years of age who had a diastolic pressure of 90 to 114 mm Hg (or <90 mm Hg with treatment). Outcome Measures: Complete data were collected on the variables of age, cholesterol, cigarette smoking, race, gender, and the presence of carotid plaque in 1126 patients. Results: All variables were significantly associated with carotid plaque (intima plus media thickness, ≥1.3 mm). The adjusted percentage with plaque was 66.4%±3.4% for blacks and 70.1%±2.3% for whites at the southern site and 42.7%±4.5% for blacks and 61.3%±3.2% for whites at the northern site. The rate of plaque was 75.8% among cigarette smokers, despite a mildly elevated cholesterol level. Conclusions: Although these 1126 cases do not constitute a random sample of patients, these data suggest that there may be regional differences in racial tendencies toward plaque among blacks.

AB - Objective: To assess the relationship between cardiovascular risk factors and carotid plaque. Design: Hypertensive patients were screened for randomization into the Multicenter Isradipine Diuretic Atherosclerosis Study, a trial intended to determine if blood pressure control by isradipine as compared with hydrochlorothiazide will blunt the progression of carotid plaque (intima plus media thickness, 1.3 to 3.5 mm) in patients with serum cholesterol levels of less than 6.85 mmol/L (265 mg/dL) without insulin-dependent diabetes mellitus or estrogen therapy. Demographics of those who underwent B-mode ultrasound evaluations at common, bifurcation, and internal carotid artery sites to detect plaque were assessed from a southern and a northern site. Setting: Participants were from ambulatory outpatient clinics associated with medical schools. Patients: The initial screening included 1823 hypertensive volunteer patients who were between 40 and 83 years of age who had a diastolic pressure of 90 to 114 mm Hg (or <90 mm Hg with treatment). Outcome Measures: Complete data were collected on the variables of age, cholesterol, cigarette smoking, race, gender, and the presence of carotid plaque in 1126 patients. Results: All variables were significantly associated with carotid plaque (intima plus media thickness, ≥1.3 mm). The adjusted percentage with plaque was 66.4%±3.4% for blacks and 70.1%±2.3% for whites at the southern site and 42.7%±4.5% for blacks and 61.3%±3.2% for whites at the northern site. The rate of plaque was 75.8% among cigarette smokers, despite a mildly elevated cholesterol level. Conclusions: Although these 1126 cases do not constitute a random sample of patients, these data suggest that there may be regional differences in racial tendencies toward plaque among blacks.

UR - http://www.scopus.com/inward/record.url?scp=0027393965&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027393965&partnerID=8YFLogxK

M3 - Article

C2 - 8435030

AN - SCOPUS:0027393965

VL - 153

SP - 501

EP - 506

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 2168-6106

IS - 4

ER -